Literature DB >> 6798056

Valproic acid and several metabolites: quantitative determination in serum, urine, breast milk and tissues by gas chromatography-mass spectrometry using selected ion monitoring.

H Nau, W Wittfoht, H Schäfer, C Jakobs, D Rating, H Helge.   

Abstract

A method has been developed for the simultaneous quantitative determination of valproic acid (2-propylpentanoic acid) and its metabolites 2-propyl-2-pentenoic acid (trans), 2-propyl-3-pentenoic acid (trans), 2-propyl-4-pentenoic acid, 3-hydroxy-2-propylpentanoic acid, 4-hydroxy-2-propylpentanoic acid, 5-hydroxy-2-propylpentanoic acid, 3-oxo-2-propyl-pentanoic acid, and and 2-propylglutaric acid. All compounds were extracted at pH 5.0 with ethyl acetate. The concentrated extracts were trimethylsilylated and the resulting mixtures analyzed by a gas chromatography-mass spectrometry-computer system operated in the selected ion monitoring mode. Linear calibration curves were obtained in the concentration ranges studied (0.1-20 microgram/ml for metabolites, 0.1-150 microgram/ml for valproic acid. The recoveries of the drugs were between 92 and 97%. The relative standard deviations were between 3.9 and 8.1% (analysis of multiple 10-microliter samples of patient urine). The lower detection limits were found to be between 2.8 and 18 ng/ml using 200-microliter serum samples. The derivatized extracts were stable for at least one week. Applications of the method described include studies of placental transfer for valproic acid and metabolites in the human, the elimination of these substances by the neonate, their transfer via mother's milk, and their levels in mouse brain.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6798056     DOI: 10.1016/s0378-4347(00)84207-3

Source DB:  PubMed          Journal:  J Chromatogr


  11 in total

1.  Effects of valproic acid, some of its metabolites and analogues on prenatal development of rats in vitro and comparison with effects in vivo.

Authors:  S Klug; C Lewandowski; F Zappel; H J Merker; H Nau; D Neubert
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

2.  The effects of phenytoin and carbamazepine on serum concentrations of mono-unsaturated metabolites of valproic acid.

Authors:  T Kondo; K Otani; T Hirano; S Kaneko; Y Fukushima
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

3.  Pharmacokinetic aspects of drug effects in vitro: effects of serum protein binding on concentration and teratogenicity of valproic acid and 2-en-valproic acid in whole embryos in culture.

Authors:  C Lewandowski; S Klug; H Nau; D Neubert
Journal:  Arch Toxicol       Date:  1986-04       Impact factor: 5.153

4.  Potent neuroprotective effects of novel structural derivatives of valproic acid: potential roles of HDAC inhibition and HSP70 induction.

Authors:  Yan Leng; Zoya Marinova; Marcos A Reis-Fernandes; Heinz Nau; De-Maw Chuang
Journal:  Neurosci Lett       Date:  2010-04-13       Impact factor: 3.046

Review 5.  Anticonvulsants during pregnancy and lactation. Transplacental, maternal and neonatal pharmacokinetics.

Authors:  H Nau; W Kuhnz; H J Egger; D Rating; H Helge
Journal:  Clin Pharmacokinet       Date:  1982 Nov-Dec       Impact factor: 6.447

Review 6.  Valproate-associated hepatotoxicity and its biochemical mechanisms.

Authors:  M J Eadie; W D Hooper; R G Dickinson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr

7.  Synthesis and evaluation of amino analogues of valproic acid.

Authors:  K R Scott; S Adesioye; P B Ayuk; I O Edafiogho; D John; P Kodwin; T Maxwell-Irving; J A Moore; J M Nicholson
Journal:  Pharm Res       Date:  1994-04       Impact factor: 4.200

Review 8.  Differentiation between valproate-induced anticonvulsant effect, teratogenicity and hepatotoxicity. Aspects of species variation, pharmacokinetics, metabolism and implications of structural specificity for the development of alternative antiepileptic agents such as delta 2-valproate.

Authors:  H Nau; H Siemes
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

Review 9.  Influence of co-medication on the metabolism of valproate.

Authors:  F Pisani
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

10.  Enzyme cytochemistry combined with electron microscopy, pharmacokinetics, and clinical chemistry for the evaluation of the effects of steady-state valproic acid concentrations on the mouse.

Authors:  R Graf; R Gossrau; H J Merker; R Schwabe; R Stahlmann; H Nau
Journal:  Histochemistry       Date:  1985
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.